CellWell record HH-526287

Serum Prostate-Specific Antigen as a Biomarker in Breast Carcinoma: A Hospital-Based Case-Control Study

H. S.; S. K; Shashwathi Nagaraju; Ganashree M. H.; D. Naik P; Sapna Patel; K. Srujan

Adolescência e Saúde · 2026

In plain language

Serum PSA was detectable in all women with breast carcinoma versus 55% of controls, suggesting a rule-out biomarker, though its low specificity and lack of correlation with disease extent limit use.

Evidence: Emerging
Design: Primary research (design unspecified)

Read it on DOI

Cite this record: https://thecellwell.org/studies/HH-526287

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.